HSP90AA1 and metastatic malignant neoplasm: These studies collectively highlight the significance of free and exosomal Hsp90 in invasive cancer and metastasis, establishing eHsp90 as a valuable biomarker for metastatic cancer and, in some cases, early cancer stages.